tiprankstipranks

Jean Jacques Bienaime Insider Profile

4 Followers
Jean Jacques Bienaime, Director at BioMarin Pharmaceutical, holds 9.62K shares in Immunome (Ticker: IMNM), holds 721.33K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds ― shares in Keros Therapeutics (Ticker: KROS). Most recently, Jean Jacques Bienaime Bought ― shares of Immunome on May 22, 2024 for an estimated value of 27.12K.
tipranks
Jean Jacques Bienaime

Jean Jacques Bienaime
BioMarin Pharmaceutical (BMRN)
Director

Ranked #29,445 out of 97,997 Corporate Insiders

Profitable Transactions

42%
18 out of 43 Profitable Transactions

Average Return

+1.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$61M
97.80%
1.95%
0.21%
0.04%
0.00% Others
A breakdown of Jean Jacques Bienaime's holdings

Insider Roles

BioMarin Pharmaceutical
(BMRN)
Director
Incyte
(INCY)
Director
Immunome
(IMNM)
Director
Immunic
(IMUX)
Director
+1 other positions
Roles that Jean Jacques Bienaime holds in companies

Most Profitable Insider Trade

Stock:
Immunic
(IMUX)
Rating:Informative Buy
Date:Apr 23, 2014 - Apr 23, 2015
Return:+138.20%
The most profitable trade made by Jean Jacques Bienaime

Jean Jacques Bienaime's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioMarin Pharmaceutical
May 21, 2024
Director
Uninformative Sell
92.61K
$60.12M
Immunome
May 22, 2024
Director
Informative Buy
27.12K
$131.82K
Keros Therapeutics
Director
Immunic
Sep 24, 2018
Director
Informative Sell
7.99K
$25.34K
Incyte
Jun 14, 2024
Director
Uninformative Buy
$1.20M
PTLA
Portola Pharma
May 16, 2014
Informative Sell
22.03K
$12.73K
NGSX
Neurogesx
Jul 26, 2011
Uninformative Buy
19.18K
$108.74
ITMN
InterMune
List of latest transactions for each holding click on a transaction to see Jean Jacques Bienaime's performance on stock

Jean Jacques Bienaime insider profile FAQ

What is the percentage of profitable transactions made by Jean Jacques Bienaime?
The percentage of profitable transactions made by Jean Jacques Bienaime is 42%.
    What is the average return per transaction made by Jean Jacques Bienaime?
    The average return per transaction made by Jean Jacques Bienaime is 1.10%.
      What stocks does Jean Jacques Bienaime hold?
      Jean Jacques Bienaime holds: BMRN, IMNM, KROS, IMUX, INCY, PTLA, NGSX, ITMN stocks.
        What was Jean Jacques Bienaime’s latest transaction?
        Jean Jacques Bienaime latest transaction was an Informative Buy of $27.12K.
          What was Jean Jacques Bienaime's most profitable transaction?
          Jean Jacques Bienaime’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
            What is Jean Jacques Bienaime's role in BioMarin Pharmaceutical?
            Jean Jacques Bienaime's role in BioMarin Pharmaceutical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.